SCHEMBL4264381

SCHEMBL4264381

CC(=O)C1C(=O)CC(C)CC1=O

nearest known ligand 0.58

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 1/20 0.39
TLR4 O00206 1/20 0.32
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1743259 0.78 TLR4 (0.32) TLR4
SCHEMBL13242146 0.78 CRBN (0.37) CRBN
SCHEMBL7965133 0.76 ALDH1A1 (0.38) CRBNTLR4
SCHEMBL20707223 0.76 MAPT (0.38)
SCHEMBL10348490 0.76 MAPT (0.38)
SCHEMBL9333656 0.75
SCHEMBL1766113 0.75 NPSR1 (0.35) NPSR1
SCHEMBL14867426 0.75 HCAR2 (0.35) NPSR1
SCHEMBL10591889 0.75 ALDH1A1 (0.35) CRBNTLR4
SCHEMBL15328544 0.74 NPSR1 (0.38) NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US claimed
EP-2838881-B1 ISOINDOLONE DERIVATIVES ABBVIE INC (US) 2018-08-08 EP disclosed
US-9776990-B2 Isoindolone derivatives ABBVIE INC. (US) 2017-10-03 US disclosed
US-20150111890-A1 ISOINDOLONE DERIVATIVES ABBVIE INC. 2015-04-23 US disclosed
EP-2850071-A1 ISOINDOLONE DERIVATIVES AbbVie Inc. (US) 2015-03-25 EP disclosed
EP-2838881-A1 ISOINDOLONE DERIVATIVES AbbVie Inc. (US) 2015-02-25 EP disclosed
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US disclosed
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US disclosed
US-8642660-B2 Method for altering the lifespan of eukaryotic organisms THE UNIVERSITY OF ROCHESTER (US) 2014-02-04 US disclosed
US-20130281450-A1 ISOINDOLONE DERIVATIVES ABBVIE INC. 2013-10-24 US disclosed
WO-2011062964-A1 COMPOUNDS AND METHODS FOR ALTERING LIFESPAN OF EUKARYOTIC ORGANISMS UNIVERSITY OF ROCHESTER (US) 2011-05-26 WO disclosed
US-20100192250-A1 Use of Fungicides for Making the Phenological Development of Oil Plants More Coherent BASF SE (DE) 2010-07-29 US disclosed
US-7686975-B2 Use of acylcyclohexanedione derivatives for improving the tolerance of plants to cold and/or frost BASF AKTIENGESELLSCHAFT (DE) 2010-03-30 US disclosed
US-20090270435-A1 Spiroketone Acetyl-CoA Carboxylase Inhibitors CORBETT JEFFREY WAYNE 2009-10-29 US disclosed
EP-2097420-A1 SPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS Pfizer Products Inc. (US) 2009-09-09 EP disclosed
US-20090163545-A1 Method For Altering The Lifespan Of Eukaryotic Organisms UNIVERSITY OF ROCHESTER (US) 2009-06-25 US disclosed
WO-2008065508-A1 SPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS PFIZER PRODUCTS INC. (US) 2008-06-05 WO disclosed
US-20070066485-A1 Use of acylcyclohexanedione derivatives for improving the tolerance of plants to cold and/or frost BASF AKTIENGESELLSCHAFT (DE) 2007-03-22 US disclosed
US-6215016-B1 HEMATOPOIETIC AGENTS; PREVENTING CYTOPENIA TORAY INDUSTRIES, INC. (JP) 2001-04-10 US disclosed
EP-0841063-A1 KETONE DERIVATIVES AND MEDICINAL USE THEREOF TORAY INDUSTRIES, INC. (JP) 1998-05-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100192250-A1 Use of Fungicides for Making the Phenological Development of Oil Plants More Coherent CYP4Z1, CYP4X1, CYP51A1 CRBN 660/4885TLR4 4738/4885NPSR1 4594/4885
US-20150111890-A1 ISOINDOLONE DERIVATIVES CYP11B1, HSD17B7, CYP4A11 CRBN 4483/4885TLR4 1920/4885NPSR1 993/4885
US-20070066485-A1 Use of acylcyclohexanedione derivatives for improving the tolerance of plants to cold and/or frost ACACB, FADS1, ACAT1 CRBN 4473/4885TLR4 3010/4885NPSR1 4294/4885
US-20090163545-A1 Method For Altering The Lifespan Of Eukaryotic Organisms TUFM, MRM1, HOGA1 CRBN 3758/4885TLR4 3880/4885NPSR1 4078/4885
US-20090270435-A1 Spiroketone Acetyl-CoA Carboxylase Inhibitors ACACA, PC, ACACB CRBN 3675/4885TLR4 2388/4885NPSR1 2555/4885
US-20130281450-A1 ISOINDOLONE DERIVATIVES CYP11B1, HSD17B7, CYP4A11 CRBN 4470/4885TLR4 1885/4885NPSR1 999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.